Based on these subgroup results, Type 1 Diabetes TrialNet is conducting a new oral insulin prevention trial to verify or refute this observation [20] (www.clinicaltrials.gov/ct2/show/NCT00419562). This evidence concerns the gene INS and type 1 diabetes mellitus.